[Clinical and immunological correlations in endogenous depression]

Area of Science:

• Neuroimmunology
• Psychiatry
• Clinical Immunology

Context:

• Endogenous depression involves complex pathophysiological mechanisms.
• Psychopharmacotherapy response varies significantly among patients.
• Inflammatory and autoimmune processes are increasingly recognized in mental health disorders.

Purpose:

• To investigate immunological parameters as potential indicators of endogenous depression activity.
• To evaluate the utility of these parameters in assessing response to psychopharmacotherapy.
• To explore the role of autoantibodies in depression's clinical presentation and treatment outcomes.

Summary:

• This study measured leukocyte elastase (LE) degranulation, alpha-1-proteinase inhibitor (alpha-1-PI) activity, and autoantibodies to S-100B neuroantigen and myelin basic protein in 42 depression patients.
• Findings confirmed the involvement of inflammatory and autoimmune responses in endogenous depression.
• Elevated autoantibodies to brain neuroantigens were associated with more complicated depression structures, prolonged courses, and resistance to therapy.

Impact:

• Immunological parameters, particularly autoantibodies, may serve as biomarkers for depression severity and treatment response.
• Identifying patients with autoimmune components could guide personalized treatment strategies.
• This research contributes to understanding the neuroimmune basis of depression and optimizing therapeutic interventions.